Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xiyanping + Azithromycin for Pediatric Mycoplasma Pneumoniae Pneumonia
NCT04296383Unknown
- Sponsor
- Jiangxi Qingfeng Pharmaceutical Co. Ltd.
- Start
- Jun 2020
- Primary completion
- Aug 2021
- Modality
- Small Molecules
01
Overview
Randomised, double-blind trial of Xiyanping injection + antibiotic in Mycoplasma pneumonia (2 arms), sponsored by Jiangxi Qingfeng Pharmaceutical Co. Ltd. Primary endpoint: Clinical recovery time. Status: unknown.
02
Drugs
Xiyanping injection + antibiotic
03
Conditions
Mycoplasma pneumonia
Beyond the preview
Go deeper on NCT04296383.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04296383.